Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality

The development and manufacturing processes for biologics are complex, and usually require advanced capabilities and specialized expertise. This has led many stakeholders in the biopharmaceutical industry to outsource significant parts of their business operations to contract service providers. The ‘Biopharmaceutical Contract Manufacturing Market (2nd edition), 2017 – 2027’ report provides an extensive study of the contract manufacturing market for biopharmaceuticals.Some of the most interesting insights from our study are presented below.

The Landscape Of Biopharmaceutical Contract Manufacturers Is Steadily Evolving
Outsourcing activities have grown significantly within the biopharmaceuticals domain; we came across 216 companies offering contract manufacturing services

CMOs Have Expanded Their Service Portfolios To Stay Competitive
In order to maintain a competitive edge in the growing contract manufacturing market, CMOs are rapidly expanding their capabilities / offerings

As The Focus On Biologics Strengthens, CMOs Are Ready To Monetize The Opportunity
The growing pipelines of emerging therapeutic classes, such as gene and cell therapies, offer lucrative business opportunities to CMOs in this domain

Likewise, The Emergence Of Biosimilars Has Reinforced The Promise
The growing biosimilars market is also expected to be one of the key growth drivers for biopharmaceutical contract manufacturers

The Manufacturing Capacity Is Well-Distributed Across The Globe
The current global contract biomanufacturing capacity is over 3.4 million litres; this is well distributed across different regions

We Expect The Overall Market To Witness a Healthy Growth Rate
Driven by an increasing global demand for biologics, we expect the market to witness significant growth over the coming decade

Specific Regions, Though, Are Likely To Garner Relatively Higher Interest
Although preferences regarding expression systems are unlikely to change, the regional contract manufacturing landscape is likely to evolve in the near future

To know more please click here For any queries / suggestions or if you’d like to get access to the full research results, please do not hesitate to contact us at sales@rootsanalysis.com

For further information on this domain, check our report here.

Roots Analysis – Research Insights

You may also be interested in the following titles:

1. China Biopharmaceutical Contract Manufacturing Market, 2020 – 2030
2. Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017 – 2027
3. Lyophilization Services for Biopharmaceuticals, 2017-2027